[1]张春 禹雪 张永辉 付芬芬 张冬洁 谢凌铎 褚福涛 栗辰 王芹芹 徐硕 解云涛*.空芯针穿刺活检在乳腺导管内乳头状肿瘤中的诊断价值[J].中国微创外科杂志,2019,01(9):800-816.
　Zhang Chun,Yu Xue,Zhang Yonghui,et al.Diagnostic Value of Core Needle Biopsy in Breast Intraductal Papillary Tumors[J].Chinese Journal of Minimally Invasive Surgery,2019,01(9):800-816.
点击复制

空芯针穿刺活检在乳腺导管内乳头状肿瘤中的诊断价值()
分享到：

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
01
期数:
2019年9期
页码:
800-816
栏目:
临床研究
出版日期:
2019-09-25

文章信息/Info

Title:
Diagnostic Value of Core Needle Biopsy in Breast Intraductal Papillary Tumors
作者:
张春 禹雪 张永辉 付芬芬 张冬洁 谢凌铎 褚福涛 栗辰 王芹芹 徐硕 解云涛*
（北京大学国际医院乳腺外科，北京102206）
Author(s):
Zhang Chun;  Yu Xue;  Zhang Yonghui;  et al.
Department of Breast Surgery, Peking University International Hospital, Beijing 102206, China
关键词:
空芯针穿刺活检; 乳腺导管内乳头状肿瘤; 低估
Keywords:
Core needle biopsy; Breast intraductal papillary tumor; Underestimation
文献标志码:
A
摘要:
目的探讨超声引导下空芯针穿刺活检（core needle biopsy，CNB）在乳腺导管内乳头状肿瘤中的诊断价值。方法回顾性分析我科2016年9月~2018年12月CNB诊断为导管内乳头状肿瘤46例48个病灶的资料，与手术切除病理进行对比。结果CNB诊断良性导管内乳头状瘤34个（70.8%），非典型导管内乳头状瘤10个（20.8%），导管内乳头状癌4个（8.3%）。除5个良性、1个非典型导管内乳头状瘤拒绝手术外，其余42个病灶行手术切除。CNB病理为良性导管内乳头状瘤，术后恶性病变所占比例为3.4%（1/29，浸润性导管癌1例）；穿刺病理为非典型导管内乳头状瘤，术后恶性病变所占比例为44.4%（4/9，均为浸润性乳腺癌）。CNB诊断导管内乳头状癌4例术后病理为浸润性癌3例，原位癌1例。拒绝手术的6例（6个病灶）随访时间8~20个月，中位时间17个月，病灶较前无明显变化。结论对于乳腺导管内乳头状肿瘤，CNB存在一定的低估可能，尤其当穿刺病理为非典型导管内乳头状瘤时，应积极手术切除活检，以避免遗漏恶性病变。
Abstract:
ObjectiveTo explore the diagnostic value of ultrasound guided core needle biopsy (CNB) in breast intraductal papillary tumors.MethodsClinical data of 46 cases of breast intraductal papillary tumors (48 lesions), diagnosed by CNB in our department from September 2016 to December 2018, were retrospectively analyzed. The pathological results of CNB were compared with those from surgery.ResultsAccording to the CNB pathological results, there were 34 lesions (70.8%, 34/48) of benign intraductal papilloma, 10 lesions (20.8%, 10/48) of atypical intraductal papilloma, and 4 lesions (8.3%, 4/48) of intraductal papillary carcinoma. Except for 5 cases of benign papilloma and 1 case of atypical intraductal papilloma who refused operation, the other 42 lesions underwent surgery. For those with CNB pathology as benign intraductal papilloma, the proportion of malignant lesions after operation was 3.4% (1/29, 1 case of invasive ductal carcinoma). For those with CNB pathology as atypical intraductal papilloma, the proportion of malignant lesions after operation was 44.4% (4/9, all invasive breast cancer). For 4 cases of intraductal papillary carcinoma diagnosed by CNB, postoperative pathology included invasive carcinoma in 3 cases and carcinoma in situ in 1 case. Six patients (6 lesions) who refused surgery were followed up for 8-20 months, with a median of 17 months. There was no significant change in the lesions.ConclusionsFor breast intraductal papillary lesions, a certain underestimation of CNB does exist, especially when the pathology result of CNB is atypical intraductal papilloma. Surgical resection should be encouraged to avoid missing malignant lesions.

参考文献/References:

[1]Grimm LJ,Bookhout CE,Bentley RC,et al.Concordant,nonatypical breast papillomas do not require surgical excision:a 10year multiinstitution study and review of the literature.Clin Imaging,2018,51:180-185.
[2]Bocker W. WHO classification of breast tumors and tumors of the female genital organs: pathology and genetics. Verh Dtsch Ges Pathol,2002,86:116-119.
[3]刘军，黄林平，陈平，等.影像引导真空辅助乳腺穿刺活检诊断乳腺微钙化的研究.中国微创外科杂志,2015,15(6):509-514.
[4]Jung I,Kim MJ,Moon HJ,et al.Ultrasonographyguided 14gauge core biopsy of the breast:results of 7 years of experience.Ultrasonography,2018,37(1):55-62.
[5]Liberman L,Tornos C,Huzjan R,et al.Is surgical excision warranted after benign,concordant diagnosis of papilloma at percutaneous breast biopsy?AJR Am J Roentgenol,2006,186(5):1328-1334.
[6]Khan S,Diaz A,Archer KJ,et al.Papillary lesions of the breast:to excise or observe?Breast J,2018,24(3):350-355.
[7]Seely JM,Verma R,Kielar A,et al.Benign papillomas of the breast diagnosed on largegauge vacuum biopsy compared with 14 gauge core needle biopsy:do they require surgical excision?Breast J,2017,23(2):146-153.
[8]Rizzo M,Linebarger J,Lowe MC,et al.Management of papillary breast lesions diagnosed on coreneedle biopsy:clinical pathologic and radiologic analysis of 276 cases with surgical followup.J Am Coll Surg,2012,214(3):280-287.
[9]Ahmadiyeh N,Stoleru MA,Raza S,et al.Management of intraductal papillomas of the breast: an analysis of 129 cases and their outcome.Ann Surg Oncol,2009,16(8):2264-2269.
[10]Chang JM,Moon WK,Cho N,et al.Management of ultrasonographically detected benign papillomas of the breast at core needle biopsy.AJR Am J Roentgenol,2011,196(3):723-729.
[11]Pareja F,Corben AD,Brennan SB,et al.Breast intraductal papillomas without atypia in radiologicpathologic concordant coreneedle biopsies:rate of upgrade to carcinoma at excision.Cancer,2016,122(18):2819-2827.
[12]Tatarian T,Sokas C,Rufail M,et al.Intraductal papilloma with benign pathology on breast core biopsy:to excise or not?Ann Surg Oncol,2016,23(8):2501-2507.
[13]Ko D,Kang E,Park SY,et al.The management strategy of benign solitary intraductal papilloma on breast core biopsy.Clin Breast Cancer,2017,17(5):367-372.
[14]Youk JH,Kim EK,Kwak JY,et al.Benign papilloma without atypia diagnosed at USguided 14gauge coreneedle biopsy:clinical and US features predictive of upgrade to malignancy.Radiology,2011,258(1):81-88.
[15]Li X,Weaver O,Desouki MM,et al.Microcalcification is an important factor in the management of breast intraductal papillomas diagnosed on core biopsy.Am J Clin Pathol,2012,138(6):789-795.
[16]Youk JH,Kim EK,Kim MJ.Atypical ductal hyperplasia diagnosed at sonographically guided 14gauge core needle biopsy of breast mass.AJR Am J Roentgenol,2009,192(4):1135-1141.
[17]Deshaies I,Provencher L,Jacob S,et al.Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy.Breast,2011,20(1):50-55.
[18]Destounis S,Seifert P,Somerville P,et al.Underestimation of papillary breast lesions by core biopsy: correlation to surgical excision.Breast Cancer,2014,21(2):128-134.
[19]Bianchi S,Bendinelli B,Saladino V,et al.Nonmalignant breast papillary lesions b3 diagnosed on ultrasoundguided 14gauge needle core biopsy:analysis of 114 cases from a single institution and review of the literature.Pathol Oncol Res,2015,21(3):535-546.
[20]Moschetta M,Telegrafo M,Carluccio DA,et al.Comparison between fine needle aspiration cytology (FNAC) and core needle biopsy (CNB) in the diagnosis of breast lesions.G Chir,2014,35(7-8):171-176.
[21]Elmore JG,Longton GM,Carney PA,et al.Diagnostic concordance among pathologists interpreting breast biopsy specimens.JAMA,2015,313(11):1122-1132.
[22]Neal L,Sandhu NP,Hieken TJ,et al.Diagnosis and management of benign,atypical,and indeterminate breast lesions detected on core needle biopsy.Mayo Clin Proc,2014,89(4):536-547.

备注/Memo

备注/Memo:
*通讯作者，Email：xieyuntao@pkuih.edu.cn
更新日期/Last Update: 2019-12-10